Navigation Links
Landmark NBC News Nutrition Report: 'There Is Indeed Little Difference Between High Fructose Corn Syrup and Table Sugar'
Date:4/23/2009

Harvard Obesity Researcher: High fructose corn syrup 'misunderstood'

WASHINGTON, April 23 /PRNewswire/ -- Last night, NBC Nightly News with Brian Williams ran a report, "The sweet truth about high fructose corn syrup," by Chief Science Correspondent Robert Bazell. In the report, Mr. Bazell noted, "Top nutrition scientists say there is indeed little difference between the two products." (http://www.msnbc.msn.com/id/21134540/vp/30355093#30355093)

In commenting on the NBC story, Audrae Erickson, president, Corn Refiners Association concluded, "This NBC Nightly News story sheds the light of day on an important health and nutrition matter for American consumers. There is no nutritional difference between high fructose corn syrup and sugar. A sugar is a sugar. It is the calories that count."

David S. Ludwig, M.D., Ph.D., Associate Professor of Pediatrics, Harvard Medical School, stated in the NBC report, "High fructose corn syrup is one of the most misunderstood products in the food supply."

"NBC got the facts right. Americans save millions of dollars every year because corn-based sweeteners are more economical to produce, while providing superior functionality in foods. In this economy, every little bit helps," reaffirmed Erickson.

In 2008, the American Medical Association said, "After studying current research, the American Medical Association concluded that high fructose syrup does not appear to contribute more to obesity than other caloric sweeteners..." (American Medical Association. June 17, 2008. Press Release: AMA finds high fructose syrup unlikely to be more harmful to health than other caloric sweeteners '/>"/>

SOURCE Corn Refiners Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Document Security Systems (Amex: DMC) Invites You to a Landmark Event
2. Less than one-third of women aware of landmark hormone therapy study, Stanford researcher finds
3. Pathway to cell death redefined in landmark study
4. Pathway to cell death redefined in landmark study
5. UCLA to lead local study center in landmark government study of child health
6. Landmark Report: Excess Body Fat Causes Cancer
7. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
8. Landmark trial to evaluate cardioprotective properties of insulin
9. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
10. Yale launches landmark VIRGO study of young women with heart disease
11. Hospital Launches Landmark Project in Emergency Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... have made a discovery that turns 160 years of ... material long known to be essential for the fast ... is not as ubiquitous as thought, according to a ... Harvard Stem Cell Institute (HSCI) and the University,s Department ... Professor Jeff Lichtman, of Harvard,s Department of Molecular and ...
(Date:4/18/2014)... Research Institute at Virginia Mason (BRI) recently received a ... metastatic breast cancer reduces both the growth of primary ... have found in models of the disease that blocking ... percent and can keep the tumor from metastasizing or ... comes from the National Cancer Institute of the National ...
(Date:4/18/2014)... French . ... medicine. A team led by Ludwik Leibler from the ... Didier Letourneur from the Laboratoire Recherche Vasculaire Translationnelle (INSERM/Universits ... the principle of adhesion by aqueous solutions of nanoparticles ... and tissues. This easy-to-use gluing method has been tested ...
(Date:4/17/2014)... of chronic inflammation in non-cancerous prostate tissue may have ... than those with no inflammation, according to results of ... Hopkins Kimmel Cancer Center. , The link between persistent ... so-called high-grade prostate cancer those with a Gleason ... of the most aggressive and rapidly growing prostate cancers. ...
(Date:4/17/2014)... most popular vaccine brands for children may not be ... some cost factors when choosing vaccines, driving the market ... to a new study by University of Illinois researchers. ... driven by numerous factors," says Sheldon H. Jacobson, a ... science and of mathematics at the U. of I. ...
Breaking Medicine News(10 mins):Health News:Finding turns neuroanatomy on its head 2Health News:Finding turns neuroanatomy on its head 3Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Study recalculates costs of combination vaccines 2
... IRVING, Texas, Dec. 13 Allarae Healthcare,Inc. (Pink Sheets: ... with Intellect, Inc. to sell their entire product line ... broad range,of personal health testing kits, several already FDA ... kits are ready for market but have,not yet been ...
... as Network Foundation for the Hospital,s ... State-of-the-Art Cardiothoracic Center, SANTA ... the completion of a new network,infrastructure to support a ... and Thurrock University Hospitals, part,of the NHS Foundation Trust ...
... shouldn,t feel like,getting your teeth drilled, according to Mirabai ... industry. For anyone who,s vowed to,start exercising in the ... help them get going. Recently released on DVD, the ... exercise,going at their own pace, so they,re more likely ...
... and females in order to alleviate back pressure from ... spearheaded at The University of Texas at Austin. , ... in the Dec. 13 issue of Nature. , The ... million years ago, in the early human ancestor Australopithecus. ...
... to allowing us to see, the mammalian eye also detects ... of this is the timing of the sleep/wake cycle, which ... pacemaker in the hypothalamus. , In a study published ... two totally blind humans whose non-visual responses to light remain ...
... 13 PARI,s eFlow, an advanced,electronic nebulizer, was ... Phase I human clinical trial. Results of the ... Annual Drug Delivery to the Lungs meeting held,in ... developed as a,treatment for respiratory syncytial virus (RSV) ...
Cached Medicine News:Health News:Allarae Healthcare Inc. Announces Signing of Distribution Agreement With Intellect Inc. 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 2Health News:Extreme Networks Provides Resilient Wired and Wireless Network to the UK's Basildon & Thurrock Hospital 3Health News:Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year 2Health News:Adapting to pregnancy played key role in human evolution, study shows 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 2Health News:Blind humans lacking rods and cones retain normal responses to non-visual effects of light 3Health News:PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase I Study 2
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... , Jan. 15, 2014 Tegra Medical is very pleased ... as its new Chief Executive Officer.  Mark was promoted ... he has overseen the company,s four facilities in ... Rica.  Mr. King joined Tegra Medical in 2012 with 20+ ...
(Date:1/15/2014)... Jan. 15, 2014  According to Millennium Research Group ... intelligence, the United States ... markets will expand moderately through 2022, with embolization ... particular, increasing interest in drug-eluting beads (DEBs) and ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle....
15 mm curved blade. 8 mm straight distal tip. Serrated on top of knife. Flat handle. Designated most popular model or size....
8 mm curved blade. Cutting edge on inside of curve. Flat handle....
For use with N4096 R, N4097 R and N4098 R. 18 mm wide x 167 mm long. Ten per package. Designated most popular model or size....
Medicine Products: